In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

The health service's vaccination scheme will also include a rollout of flu and Covid-19 vaccines. 'Vitally important' Dr ...

Physicians in PA don’t expect to see the surges they saw during the first winters of the COVID-19 pandemic, but encouraged ...

Just over a fifth of US adults aged 60 and older had been vaccinated against RSV as of March 2024, with disparities seen by ...

Fiona P. Havers, MD, MHS, spoke with Physician’s Weekly about managing RSV as a newly vaccine-preventable disease now that ...

While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...

Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and ...

Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) antiviral reduced the viral load in a phase 2 study in children, ...

RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.

China's Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK's shingles ...

It's respiratory virus season, and statewide and local numbers show the gradual rise in cases. Here is what you can do.

Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...